Raiffeisen Bank International AG purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 4,866 shares of the company's stock, valued at approximately $574,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Barclays PLC raised its position in Cardinal Health by 8.2% during the third quarter. Barclays PLC now owns 707,404 shares of the company's stock worth $78,183,000 after acquiring an additional 53,851 shares in the last quarter. Park Avenue Securities LLC increased its stake in shares of Cardinal Health by 17.5% during the 4th quarter. Park Avenue Securities LLC now owns 24,426 shares of the company's stock worth $2,889,000 after purchasing an additional 3,643 shares during the last quarter. Thurston Springer Miller Herd & Titak Inc. raised its holdings in shares of Cardinal Health by 21.6% in the 4th quarter. Thurston Springer Miller Herd & Titak Inc. now owns 821 shares of the company's stock valued at $97,000 after purchasing an additional 146 shares during the period. Gateway Investment Advisers LLC raised its holdings in shares of Cardinal Health by 98.6% in the 4th quarter. Gateway Investment Advisers LLC now owns 12,154 shares of the company's stock valued at $1,437,000 after purchasing an additional 6,034 shares during the period. Finally, Empirical Asset Management LLC acquired a new stake in Cardinal Health in the 4th quarter valued at about $859,000. Institutional investors own 87.17% of the company's stock.
Wall Street Analysts Forecast Growth
CAH has been the topic of a number of recent analyst reports. JPMorgan Chase & Co. boosted their price target on Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Argus set a $148.00 target price on Cardinal Health in a report on Tuesday, February 4th. Mizuho increased their price target on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research note on Monday, March 31st. Robert W. Baird raised their price target on Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a report on Friday, May 2nd. Finally, Wells Fargo & Company upped their price objective on shares of Cardinal Health from $135.00 to $136.00 and gave the company an "equal weight" rating in a report on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $146.43.
Check Out Our Latest Stock Analysis on Cardinal Health
Cardinal Health Stock Performance
NYSE:CAH traded down $0.14 during mid-day trading on Friday, reaching $152.35. 572,599 shares of the company's stock were exchanged, compared to its average volume of 2,520,127. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $156.43. The business's fifty day simple moving average is $139.15 and its two-hundred day simple moving average is $128.82. The firm has a market capitalization of $36.36 billion, a PE ratio of 28.42, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66.
Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The firm had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. During the same quarter in the prior year, the business posted $2.08 EPS. The business's revenue was up .0% compared to the same quarter last year. As a group, equities research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current year.
Cardinal Health Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This is a boost from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a yield of 1.34%. Cardinal Health's payout ratio is currently 31.83%.
Cardinal Health Company Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.